BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37898869)

  • 21. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to cancer screening guidelines across Canadian provinces: an observational study.
    Strumpf EC; Chai Z; Kadiyala S
    BMC Cancer; 2010 Jun; 10():304. PubMed ID: 20565862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
    Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
    Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
    BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
    Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
    Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
    Nielsen JB; Berg-Beckhoff G; Leppin A
    BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
    Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cost-effectiveness analysis on colorectal cancer screening program].
    Huang QC; Ye D; Jiang XY; Li QL; Yao KY; Wang JB; Jin MJ; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):65-68. PubMed ID: 28100379
    [No Abstract]   [Full Text] [Related]  

  • 30. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
    Buchman S; Rozmovits L; Glazier RH
    Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
    Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
    Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer-Experience from a Hospital in Central Taiwan.
    Yang PY; Yang IT; Chiang TH; Tsai CH; Yang YY; Lin IC
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109638
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of public knowledge, attitudes, and behavior on willingness to undergo colorectal cancer screening using the health belief model.
    Almadi MA; Mosli MH; Bohlega MS; Al Essa MA; AlDohan MS; Alabdallatif TA; AlSagri TY; Algahtani FA; Mandil A
    Saudi J Gastroenterol; 2015; 21(2):71-7. PubMed ID: 25843192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA.
    Honeycutt S; Green R; Ballard D; Hermstad A; Brueder A; Haardörfer R; Yam J; Arriola KJ
    Cancer; 2013 Aug; 119(16):3059-66. PubMed ID: 23719894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a home-based colorectal cancer screening intervention in a rural state.
    Charlton ME; Mengeling MA; Halfdanarson TR; Makki NM; Malhotra A; Klutts JS; Levy BT; Kaboli PJ
    J Rural Health; 2014; 30(3):322-32. PubMed ID: 24164375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
    Willauer AN; Zuckerman MJ; Alomari A; Alvarado LA; Salaiz R; Casner N; Dwivedi AK; Shokar NK
    Am J Med Sci; 2022 Oct; 364(4):394-403. PubMed ID: 35398033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
    Zorzi M; Zappa M;
    Gut; 2020 Feb; 69(2):311-316. PubMed ID: 31040168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.